These groundbreaking findings not only indicate the involvement of FGFR1 in the pathogenesis of BLCA, but more importantly, reveal a distinct signaling network regulated by this pathway in BLCA. This evidence concerns the gene FGFR1 and bladder transitional cell carcinoma.